Disease Activity
8
1
2
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (8)
Isthmin-1 as a Biomarker of Disease Activity in Rheumatoid Arthritis: Correlation With Musculoskeletal Ultrasound Findings
The Effect of Cold Application in Patients With Rheumatoid Arthritis
Evaluation of Intestinal Lesions and Disease Activity in Inflammatory Bowel Disease Based on 18F-FAPI PET Imaging
Maresin-1 and Resolvin-D1 Levels and Disease Activity in Ulcerative Colitis
The Effects of Aerobic Exercise in Patients With Ankylosing Spondylitis
Effect of Aerobic Exercises on Axial Spondyloarthropathy
14.0- 3.0- 3.0- η Protein With Rheumatoid Arthritis
Effect of Cholecalciferol Supplementation on Disease Activity and Quality of Life of Systemic Lupus Erythematosus Patients .